Femoropopliteal-crural graft patency is improved by an intensive surveillance program: A prospective randomized study  by Lundell, Anders et al.
Femoropopliteal-crural graft patency is 
improved by an intensive surveillance 
program: A prospective randomized study 
Anders Lundell, MD, PhD, Bengt Lindblad, MD, PhD, David Bergqvist, MD, PhD, 
and Fleming Hansen, MD, Malmo, Sweden 
Purpose: The purpose of this study was to evaluate whether intensive surveillance ompared 
with routine follow-up examinations improves femoropopliteal/crural graft patency. 
Methods: After operation the patients were randomized to intensive (n = 79) or routine 
surveillance (n = 77). The groups were matched with regard to sex, diabetes, indication 
for surgical procedure, surgical procedure, and graft material. Intensive surveillance was 
clinical examination, ankle/brachial index measurements, and duplex scans 1, 3, 6, 9, 12, 
15, 18, 21, 24, and 36 months after operation. Routine surveillance was clinical 
examination and ankle/brachial index measurements without duplex scanning 1, 12, 24, 
and 36 months after operation. Grafts with a decrease in ankle/brachial index of more than 
0.15 compared with the initial postoperative ankle/brachial ndex or a duplex scan showing 
a graft or anastomotic stenosis of more than 50% underwent angiography and if necessary, 
a revision or repeat procedure. Occluded grafts were reopened with thrombectomy or
thrombolysis or were replaced with a new graft. 
Results: Assisted primary cumulative vein graft patency in the intensive group (n = 56) 
compared with that in the routine surveillance group (n = 50) after 3 years was 78% 
versus 53% (chi square analysis, 4.51; one degree of freedom; p < 0.05). Secondary 
patency was 82% versus 56% (chi square analysis, 5.62; one degree offreedom;p < 0.05). 
Assisted primary cumulative -polytetrafluoroethylene and composite graft patency after 
1 year in the intensive group (n = 23) compared with that of the routine surveillance 
group (n = 20) was 57% vs 50% (chi square analysis, 2.17; one degree of freedom; 
p > 0.1). Secondary patency was 67% vs 54% (chi square analysis, 1.85; one degree of 
freedom; p > 0.1). Revisions were made on 14 patent and 10 thrombosed grafts in the 
intensive group and on four patent and 15 thrombosed grafts in the routine surveillance 
group. All except eight were made during the first postoperative y ar. 
Conclusions: Intensive surveillance identified failing vein grafts leading to a significantly 
higher cumulative assisted primary and secondary patency compared with cumulative 
assisted primary and secondary patency after outine follow-up examination. The patency 
of e-polytetrafluoroethylene and composite grafts was not influenced by intensive 
surveillance. (J VASC SURG 1995;21:26-34.) 
The success of  a femorocrural reconstruction 
depends on the patient selection, the operative 
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procedure, and possibly postoperative surveillance. It 
is more difficult to restore patency in a thrombosed 
graft than to make a revision to maintain patency on 
a hemodynamically failing but still open graft. 1,2 The 
importance of  a postoperative surveillance program 
in detecting failing grafts has been stressed by 
others. 3,4 However, no prospective randomized 
study evaluating whether intensive postoperative 
surveillance actually leads to increased patency has 
been published. 
Our aim with this study was to investigate in a 
prospective randomized series whether an intensive 
postoperative surveillance program compared with 
routine surveillance would assist in improving pa- 
tency after femorocrural reconstruction with regard 
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Table I. Patient material, presence of 
diabetes, and indication for operation 
Intensive Routine 
Age (yrs) 74 (66-81) 76 (66-81) 
Sex 40 Female 45 Female 
39 Male 32 Male 
Diabetes 29/79 25/77 
Intermittent claudication 2 2 
Rest pain 33 29 
Ischemic ulcer 23 31 
Gangrene 16 14 
Popliteal aneurysm 5 1 
both to vein and e-polytetrafluoroethylene ( PTFE) 
and composite grafts. 
MATERIAL AND METHODS 
Patients from the city of Maim6 undergoing a
primary femoropopliteal or femorodistal reconstruc- 
tion from January 1,1988, to August 31, 1992, at the 
Department of Surgery, Malm6 General Hospital, 
included. Indication for surgical procedure was 
critical leg ischemia (presence of rest pain with a 
duration of more than 2 weeks, ischemic ulcer or 
gangrene of any part of the foot) or popliteal 
aneurysm. Patients with intermittent claudication 
underwent operation only if their symptoms were 
considered to diminish their quality of life. The 
preoperative examinations included an aortofemoral 
angiography, a chest x-ray examination, and an 
electrocardiographic examination. The patients un- 
derwent operation while they were under epidural 
anesthesia~ Autologous aphenous vein (reversed or 
in situ) was used as graft material for reconstructions 
with the distal anastomosis below knee level. Com- 
posite grafts (proximal part ePTFE and distal part 
autologous aphenous vein) were used when the 
length and quality of the available vein were insuffi- 
cient. For reconstructions with the distal anastomosis 
above knee level, ePTFE was used. After the recon- 
struction was completed and before the wound was 
closed, the reconstruction was assessed with a table 
angiogram and a handheld continuous Doppler 
scanner. A total of 6 gm antibiotic prophylaxis 
(Cloxacillin, Ekvacinin, As tra AB, Sweden) was given 
in three doses as intravenous infusion during the 
surgical procedure and at 12-hour intervals during 
the first 24 postoperative hours. Dextran (Macro&x, 
Pharmacia AB, Sweden) was used as a thrombosis 
prophylaxis; 1000 ml was administered during the 
surgical procedure and for the first 24 postoperative 
hours. The patients received a further dose of 500 ml 
dextran during the first to third postoperative days. 
Table II. Type of reconstruction and 
graft material 
Vein Reversed 
in situ vein Composite PTFE 
Intensive surveil- 
lance group 
Femoropopfiteal 1 1 0 15 
above knee 
Femoropopliteal 29 6 2 2 
below knee 
Femorodistal 15 4 3 1 
Routine surveil- 
lance group 
Femoropopliteal 2 0 0 16 
above knee 
Femoropopfiteal 28 3 1 6 
below knee 
Femorodistal 13 4 4 0 
Randomization toan intensive surveillance group or 
to a routine surveillance group was done after the 
surgical procedure. The study was approved by the 
Ethics Committee, University of Lurid, and patient 
consents were obtained. 
Surveillance. Intensive surveillance was done 
during outpatient visits to a vascular surgeon 1, 3, 6, 
9, 12, 15, 18, 24, and 36 months after the operation. 
These visits included clinical examination of the graft, 
an ankle/brachiat index (3331) measurement, and a 
duplex scan. Routine surveillance was conducted 
during outpatient visits to a vascular surgeon. These 
visits included clinical examination of the graft and 
measurement of ABI but did not include duplex 
scans. They were done 1, 12, 24, and 36 months after 
the operation. Surveillance data were registered in 
separate protocols. Data from each examination were 
sent to the study controller, who decided whether 
further investigations should be made. 
Duplex. The duplex scans were performed by a 
vascular technician. A Diasonic CV 400 (Diasonics, 
Inc., Milpitas, Calif.) with a 7.5 MHz B-mode real- 
time scanner and a 4.5 MHz pulsed Doppler scanner 
were used, and after January 1990 an Acuson XP 10 
(Acuson, Inc., Mountain View, Calif.) with a 5 MHz 
B-mode real-time scanner and a 3.5 MHz pulsed and 
color Doppler scanner were used. The whole length 
of the graft including the proximal and distal 
anastomosis was examined. A graft stenosis of more 
than 50% was thought o be present when the peak 
flow velocity exceeded 200 cm/sec at any part of the 
graft, s Peak flow velocities less than 45 cm/sec were 
considered to indicate an inflow or outflow vessel 
stenosis. 6 Graft stenoses less than 50% were not 
registered. 
Angiography. Patients with signs of a failing 
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Table III. Angiographic findings and type of revision in Failing grafts 
Intensive Routine 
Graj~ material Ve in  ePTFE/Composite Ve in  ePTFE/Composite 




Revisions in failing grafts 
Patch angioplasty 
Ligature of arterioventricular fistula 
PTA/distal anastomosis 
2 0 0 0 
7 2 3 0 
3 0 1 0 
7 1 2 0 
3 0 1 0 
2 1 1 0 
graft such as sudden onset of disabling claudication, 
ischemic pain, or debut of ischemic ulcers, an ABI 
decrease of more than 0.15 compared with the 
initial postoperative ABI, or in the intensive sur- 
veillance group, a duplex scan showing a graft or 
anastomosis stenosis of more than 50%, underwent 
an angiography. 
Revision. If the angiography showed a graft 
stenosis of more than 50%, a revision (patch an- 
gioplasty, percutaneous transluminal angioplasty 
[PTA], insertion of a new graft segment) was made. 
Arterioventricular fistulas causing a failing graft 
were ligated. Graft occlusion was suspected when 
a sudden onset of critical leg ischemia nd loss of 
palpable graft pulses occurred. If the diagnosis was 
uncertain, an angiography was made. Repeat pro- 
cedures included graft thrombectomy or, from the 
beginning of 1993, thrombolysis for reopening 
occluded grafts and replacement of infected or 
occluded grafts with new grafts. 
Follow-up and statistics. The follow-up exami- 
nations were continued for 3 years. The analysis of 
the results was done on an intention-to-treat basis. 
Assisted primary and secondary patency, revision, 
and repeat procedures were defined in accordance 
with the Ad Hoc committee on reporting standards.7 
Data are median and interquartile range. For statis- 
tical analysis Wilcoxon's rank sum test, Fisher's exact 
test, and two-tailed test were used. Life-table data 
were compared with log rank test according to Peto 
et al.s The p valucs less than 0.05 were considered 
significant. 
RESULTS 
A total of 156 patients, 84 women and 72 men, 
were studied. Randomization to the intensive surveil- 
lance group was made for 79 patients and the routine 
surveillance group for 77 patients. Age, sex distribu- 
tion, presence of diabetes, and indication for surgical 
proccdure did not differ between groups (Table I). 
The surgical procedure and type of graft material 
did not differ between the groups (Table II). Three 
patients, two in the intensive surveillance group (one 
vein and one ePTFE graft) and one (ePTFE graft) in 
the routine surveillance group, were lost to follow-up 
examination after a median of 15 months. The 
preoperative ABI in the intensive surveillance group 
was 0.41 (0.28 to 0.50), and in the routine surveil- 
lance group it was 0.35 (0.15 to 0.50) (ns). The 
1-month postoperative ABI was 0.85 (0.65 to 1.00) 
in the intensive surveillance group and 0.83 (0.70 to 
1.00) in the routine surveillance group (NS). No 
difference was seen in the preoperative ABI between 
patients with patent grafts (0.40 (0.28 to 0.50)) and 
patients with grafts that eventually occluded (0.36 
[0.17 to 0.50]). The 1-month ABI did not differ 
between patients with grafts that remained patent 
(0.83 [0.67 to 0.96]) and patients with grafts that 
occluded (0.85 [0.69 to 1.00]). Angiography was 
performed on 42 patients (27 in the intensive 
surveillance group and 15 in the routine group) 
including all patients with grafts undergoing a 
subsequent revision. The indication for angiography 
for patients who eventually turned out to have patent 
grafts was onset of critical eg ischemia (rest pain or 
ischemic ulcer) in two vein and three ePTFE grafts in 
the intensive surveillance group and four ePTFE 
grafts in the routine surveillance group. In two 
ePTFE grafts in the routine surveillance group a 
decrease was seen in the ABI. Graft occlusion was 
verified by angiography in one vein and seven ePTFE 
grafts in the intensive surveillance group and in two 
ePTFE grafts in the routine surveillance group. 
Failing grafts. Surveillance identified 18 falling 
grafts, which were revised (Table III). Time to 
revision was 255 days (range 137 to 306 days); 14 
revisions were made during the first postoperative 
year, and the remaining four were made during the 
second year. No patient died within 30 days of graft 
revision. The revised grafts remained patent for the 
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Fig. 1. Most graft occlusions occurred uring first postoperative y ar. Late failures were 
pPTFE and composite grafts. 
duration of the follow-up period. Thirteen grafts 
(nine vein and two ePTFE in the intensive surveil- 
lance group and two vein grafts in the routine 
surveillance group) were found with a combination 
of ABI measurements and duplex scanning. Duplex 
examinations alone identified three failing vein grafts 
in the intensive surveillance group without any signs 
of decrease in ABI. Two patients with failing vein 
grafts in the routine surveillance group had a sudden 
onset of rest pain. In addition two graft infections 
occurred: one ePTFE graft in the intensive surveil- 
lance group and one in situ vein graft in the routine 
surveillance group. The infected grafts were replaced 
with new grafts. 
Graft occlusion. A total of 65 grafts occluded: 
27 in the intensive surveillance group and 38 in the 
routine surveillance group. Eleven vein graft occlu- 
sions were in the intensive surveillance group, and 20 
were in the routine surveillance group. Most of the 
occlusions occurred uring the first 12 postoperative 
months (Fig. 1). 
Median time to graft occlusion from surgical 
procedure was 176 days (range 52 to 423 days) for 
both groups. The median time from the last outpa- 
tient visit to occlusion was 48 days (range 19 to 60 
days) in the intensive surveillance group compared 
with 113 days (range 40 to 223 days) in the routine 
surveillance group (p < 0.01). In three patients 
(with two vein and one ePTFE graft) in the intensive 
surveillance group a decrease was seen in ABI and a 
duplex-verified anastomotic stenosis, but before re- 
vision was made the grafts occluded. Two patients 
did not want to participate in the surveillance 
program after their 6-month visit, and one patient 
had a myocardial infarction and subsequent graft 
occlusion. For 21 graft occlusions (eight vein, three 
composite, and 10 ePTFE grafts) in the intensive 
surveillance group and for the occlusions in the 
routine surveillance group no cause for the occlusion 
was registered. 
The occlusion was diagnosed clinically and veri- 
fied by angiography in 11 patients. Revisions on 
occluded grafts were made on 10 grafts in the 
intensive surveillance group and on 15 grafts in the 
routine surveillance group (Table IV). Most (20) of 
the revisions on occluded grafts were made during 
the first postoperative y ar, three were made during 
the second year, and two were made during the third 
postoperative y ar. 
The revisions on occluded grafts were successful 
in seven (two vein and five ePTFE or composite) 
grafts in the intensive surveillance group and in three 
JOURNAL OF VASCULAR SURGERY 
30 Lundell et al. January 1995 
Table IV. Reoperative procedures in occluded grafts 
Graft material Vein 
Reoperative procedures on occluded grafts 
Intensive Routine 
ePTFE/Composite Vein ePTFE/Composite 
Thromboectomy 0 3 2 4 
Revision 2 2 3 3 
New graft 0 3 0 3 
(one vein and two ePTFE or composite) grafts in the 
routine surveillance group (p < 0.05). The primary 
assisted vein graft patency rate was significantly 
higher in the intensive surveillance group compared 
with that in the routine surveillance group (chi square 
analysis, 4.51; one degree of freedom, p < 0.05). 
The secondary vein graft patency was significantly 
higher in the intensive surveillance group com- 
pared with that in the routine group (chi square 
analysis, 5.62; one degree of freedom, p < 0.05) 
(Fig. 2). 
The number of patent ePTFE and composite 
grafts was too low from 1 year onward to permit 
statistical analysis. Up to 1 year after the operation 
the assisted primary (chi square analysis, 2.17; one 
degree offreedom;p > 0.1) and secondary patencies 
(chi square analysis, 1.85; one degree of freedom; 
p > 0.1) for ePTFE and composite grafts did not 
differ between the two groups (Fig. 3). 
DISCUSSION 
Study design. Intensive surveillance compared 
with routine surveillance significantly increased cu- 
mulative secondary vein graft patency. The results 
with regard to ePTFE and composite graft patency 
were not significant. The study was designed in 1987 
when the value of intensive surveillance after femo- 
rocrural reconstruction had been suggested. 9 Since 
then more studies upporting the positive effect of 
intensive surveillance on vein graft patency in par- 
6cular have appeared. ~°,11 However, no randomized 
studies have been published, and the xtra cost and 
effort made it essential to carefully evaluate surveil- 
lance before it was generally accepted. This study was 
therefore made in a randomized manner. 
Only one hospital has been involved, and there- 
fore indication for surgical procedure was similar for 
both groups. Patient compliance has also been high 
with only two dropouts from the surveillance pro- 
gram. (Both patients were randomized to intensive 
surveillance, and both had a subsequent graft occlu- 
sion.) During the study several reports about the 
significance of an intensive graft surveillance were 
published. These reports made it questionable to 
prolong patient randomization. One disadvantage 
with the study design was that the results from 
surveillance were evaluated by one study controller 
with a possible risk of delay between diagnosis and 
revision. This fact and the subsequent delay between 
verified stenosis and revision may explain three (two 
vein and one PTFE) graft occlusions in the intensive 
surveillance group. In these patients urveillance data 
indicated failing grafts, but the grafts occluded before 
revision could be made. 
Failing grafts. The diagnosis of failing graft 
resulting from sudden onset of ischemic symptoms 
was made in only two patients (both in the routine 
surveillance group). During the study it became 
obvious that clinical diagnosis was inadequate for 
identifying patients with failing grafts. For surveil- 
lance of femoropopliteal-crural reconstructions it 
seems uboptimal to rely on surveillance based on a 
clinical deterioration of symptoms. 
Interestingly no difference was seen in the 
1-month postoperative ABI between grafts that 
remained patent and grafts that eventually failed. This 
finding has also been pointed out by others. 12,13 A 
decrease in ABI identified 13 failing grafts. The 
diagnosis was verified by the duplex examinations. 
Out of 18 failing grafts 13 (72%) were identified by 
ABI measurements, a proportion close to that found 
by other groups.14,1s Duplex scanning identified three 
(17%) failing vein grafts with no decrease in ABI in 
the intensive surveillance group. As others have 
pointed out the addition of duplex scanning should 
reveal failing grafts not found by a decrease inABI. 16 
The two patients in the routine surveillance group 
who underwent duplex scanning were not treated 
according to the study protocol. 
These examinations were done during the fall of 
1993, more than 1 year after the last patient had been 
admitted to the study and when the value of duplex 
scanning had become vident o all members of the 
vascular team. In the routine surveillance group the 
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Fig. 2. Cumulative assisted and secondary vein graft patency was significantly higher in 
intensive surveillance group compared with routine surveillance group (chi square analysis, 
4.51; one degree of fteedom;p < 0.05; and chi square analysis, 5.62; one degree of freedom; 




long interval between examinations was probably the 
main reason for the low number of identified failing 
grafts. Surveillance based on clinical examination and 
measurement of ABI at short regular intervals will 
identify close to two thirds of all failing grafts, but the 
ultimate vein graft surveillance should be based on 
duplex examinations. 
The canse for the occlusion was registered for six 
of the graft failures in the intensive surveillance 
group, but for the remaining occlusions in both 
groups no cause has been registered. Patients with 
vein grafts in the intensive surveillance group could 
have had borderline changes in the duplex examina- 
tions before the occlusion. 
Only patients with a stenosis of more than 50%, 
which was indicated by a peak flow velocity less than 
45 cm/sec or in some instances more than 200 
cm/sec, underwent angiography and later graft revi- 
sion. Stenoses less than 50% were not registered. 
This attitude could be questioned, especially because 
the total number of graft occlusions in spite of 
intensive surveillance was high. It has been suggested 
that patency in grafts with stenoses less than 50% is 
improved by revision. 17 We found that l0 of the 12 
vein graft stenoses were located at the distal anasto- 
mosis, and only two were in the graft itself. This 
finding is in contrast o the findings of other groups, 
where most stenoses were located in the graft) 8 One 
plausible explanation for this discrepancy could be 
that the duplex examinations during the first 2 years 
were done without color coding. In spite of intensive 
surveillance, failing ePTFE or composite grafts were 
not identified. The lack of influence of intensive 
surveillance on ePTFE or composite graft patency is 
reflected in the cumulative patency rates, which did 
not differ between the groups. Patients undergoing 
operation with ePTFE or composite grafts should 
perhaps be submitted to a surveillance program not 
based on duplex examinations) 9 Digital subtraction 
angiography performed at regular postoperative 
intervals has been suggested to be a better alter- 
native. 2° 
JOURNAL OF VASCULAR SURGERY 












Cumulat ive ePTFE and Composite graft patency 
i . . . .  , 
IiL_o._.__ I,, I . . . . . .  Iq o -  -- - ¢ -  
. . . . . .  - ]  8%___  
Numbers at risk: 
o Intensive surveillance assisted primary patency 
* Intensive surveillance secondary patency 
• Routine surveillance assisted primary patency 
[] Routine surveillance secondary patency 
I I I I i 
3 6 9 12 15 
I I I 
LA...~ 
0 1 3 6 9 12 15 18 21 24 36months 
23 21 19 16 14 12 9 8 6 6 3 
23 22201817 14 11 10 8 8 2 
27 23201716 13 11 11 9 8 5 
27 24 21 18 17 15 13 13 11 10 7 
I i t I 





[ I I-" 
i 
t_ I --t.-.~-.----..-..---~ 
Months 
t I I 
30 33 36 
Fig. 3. No difference in patency was seen between ePTFE and composite grafts in intensive 
surveillance group compared with routine surveillance group. From 1 year onward number of 
patent grafts was too small to permit statistical nalysis. 
Occluded grafts. The significant difference of 
successful revisions on occluded grafts between the 
two groups seems to be due to the fact that the graft 
occlusions in the routine group were diagnosed too 
late to permit a successful revision. This occurrence is
reflected in a significantly longer time from the 
preceding outpatient visit to occlusion in the routine 
group compared with that of the intensive surveil- 
lance group. It seems that intensive surveillance not 
only identifies failing grafts but also makes a higher 
successful revascularization rate possible after an 
occlusion. This finding can be partly explained by the 
shorter interval between the outpatient visit and graft 
occlusion in the intensive group compared with that 
of the routine surveillance group. 
Revisions. The preferred procedure for graft 
revision was patch angioplasty. The results have been 
encouraging with no postoperative d aths and patent 
grafts for the duration of the follow-up period. Our 
experiences with PTA are limited, but the results 
from this study seem equal to those of patch 
angioplasty. We do therefore use PTA more often 
now for correction of vein graft stenoses, particularly 
because our radiologists are becoming more familiar 
with the technique. However, the possibility of a 
restenosis after PTA has to be considered. 16For 
ePTFE graft stenosis caused by intimal hyperplasia n
the anastomosic regions, we still consider patch 
angioplasty the method of choice. 
Experiences. Most of the failing grafts and graft 
occlusions in the study were found during the first 
year. Based on the results from this study the 
examinations in our surveillance program are con- 
centrated to the first postoperative y ar. Outpatient 
visits include duplex and ABI measurements 1, 3, 6, 
9, 12, and 24 months after the surgical procedure, 
which is in accordance with other suggested regi- 
mens. 21 Both vein and ePTFE and composite grafts 
are examined. The ABI measurements and the clinical 
examination are done by an outpatient nurse, and the 
duplex examinations are done by a vascular techni- 
cian. I f  the examinations show signs of a failing graft 
including a suspect graft stcnosis less than 50%, the 
patient is examined by a vascular surgeon who 
decides whether the interval to the next duplex 
examination should be shortened or an angiography 
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should be done. It  has been reported that more failing 
grafts might be identified, if the intervals between 
visits were only 6 weeks for the first 6 months. 22 
However,  a risk exists that the advanced age of  the 
patients and their limited mobil ity in spite o f  patent 
grafts and viable fimbs could make such a program 
impractical. On  the other hand the consequences of
a graft occlusion for this group o f  patients are severe, 
making it important o have an optimal surveillance 
to maintain femorocrural graft patency. 23 
Intensive surveillance based on ABI  and duplex 
examinations at short intervals during the first and 
second postoperative year identified failing vein 
grafts, which led to a significantly higher vein graft 
patency after revision compared with patency after 
routine follow-up examinations. The patency of  
ePTFE and composite grafts was not influenced by 
intensive surveiUance. 
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DISCUSSION 
Dr. Dennis F. Bandyk (Tampa, Fla.). Previous tudies 
deafing with infrainguinal graft surveillance were prospec- 
tive cohort rials but lacked an appropriate control group. 
The study conducted by Dr. Lnndell and his colleagues i
the first randomized clinical trial reported. Both vein and 
PTFE grafts were studied, and the intensive surveillance 
protocol included color duplex scanning. Duplex scanning 
was compared with clinical assessment and measurements 
of ankle systolic pressure. The study outcome confirmed 
duplex surveillance increased secondary and cumulative 
graft patency compared with clinical evaluation, but the 
benefit was observed only after vein bypass grafting. 
Intensive surveillance did not improve the patency ofPTFE 
or PTFE composite grafts. Overall the graft patency rates 
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of this study were comparable to other recent reports of 
infrainguinal bypass in patients with critical imb ischemia. 
Randomization ofpatients was performed after operation, 
but graft surveillance was not initiated until a month later. 
Thus the influence of duplex surveillance on early graft 
failure was not examined, and indeed the 30-day graft 
• failure rates were the same in both study groups. 
A novel feature of this study was the use of a study 
controller who reviewed the data from each study group 
and then decided what further investigations were neces- 
sary. This aspect of the study design introduced elay in the 
evaluation of patients who were identified to have failing 
grafts. All abnormal grafts were subjected to angiographic 
confirmation of the duplex-identified abnormality before 
revision. In the article the authors admit the delay 
introduced by this process accounted for approximately 
20% of the vein graft failure in the intensive surveillance 
group. Given that the duplex criteria were used to identify 
a graft stenosis, I was surprised that a greater number of 
abnormalities were not detected, particularly at the 1- and 
3-month scan times. Since 42 patients had postoperative 
arteriography, I would like to ask the authors whether the 
accuracy of duplex scanning was calculated. How often 
were intrinsic graft stenoses or anastomotic abnormalities 
not detected by duplex scanning? 
The number of graft occlusions that developed espite 
surveillance was also a concern. When changes in graft 
function were detected, and duplex scanning identified a 
stenosis, the surveillance protocol was not altered. For 
lesions that did not meet he criteria for revision, progres- 
sion to graft thrombosis may have occurred before the next 
scheduled visit. How did the authors follow lesions with 
borderline criteria for further evaluation or revision? Of 
note, 77% of vein graft occlusions and two thirds of PTFE 
graft occlusions occurred within 9 months of the proce- 
dure, and this incidence was not decreased by intensive 
surveillance. The earliest graft revision was undertaken at 
4.5 months. This outcome varies from my experience with 
duplex surveillance of in situ saphenous vein bypass where 
10% of revisions were performed within 1 month of 
operation, and one third occurred within 3 months. 
I would like the authors to comment on whether they 
observed a learning curve in the application of duplex 
surveillance in this study. I have found that with time our 
technologists and the surgeons have improved the scanning 
technique and interpretation ofduplex graft examinations. 
Do the authors believe the observed incidence of graft 
occlusion was the result of failed graft revision proce- 
dures or inadequate graft surveillance, for example, too 
infrequent testing schedule or improper duplex criteria for 
intervention? Finally, given the results for postoperative 
surveillance of PTFE grafts, what are the authors' recom- 
mendations regarding follow-up of prosthetic bypasses? 
Dr. Anders Lundell. The study was designed in 1987 
and started in 1988. At that time we had limited experience 
in graft surveillance, so there is a considerable l arning 
curve in the study. Duplex scanning identified 14 stenoses, 
and angiography confirmed 12, which I think is a fairly 
high accuracy for duplex scanning. 
When we found duplex abnormalities indicating bor- 
derline stenosis, we adhered to the protocol, and action was 
not taken until there was a graft stenosis of more than 50%. 
The main cause for graft occlusions must have been 
inadequate graft surveillance. I did not mention it in the 
speech, but all our revisions have been successful, with no 
postoperative deaths after revision, and the grafts have 
remained patent for the duration of follow-up. 
The results with regard to ePTFE and composite grafts 
have given us great concern. Duplex scanning did not 
identify failing grafts, and neither did ABI. The patients 
had a sudden occlusion that came without any preceding 
symptoms. We are now discussing whether we should 
change the surveillance, not making duplex scans but 
perhaps instead digital subtraction angiography, but then 
you have the cost problem. You must also take into 
consideration that there was a steady decline of patent 
ePTFE grafts. The majority of vein graft occlusions were 
during the first postoperative year, whereas the ePTFE 
graft occlusions occurred from the first to the third 
postoperative y ar. That means that we shall perhaps have 
a program that follows these grafts for a longer period than 
3 years. 
Dr. Norman R. Hertzer (Cleveland, Ohio). I might 
just comment that, as those of you in the United States 
know, the Health Care Financing Administration has been 
reluctant to reimburse for ongoing surveillance of synthetic 
grafts, whereas itwill reimburse for ongoing surveillance of 
autogenous grafts. This work tends to support that 
conclusion. 
